ArticleMolecular therapy : the journal of the American Society of Gene Therapy2018

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors.

Xingli Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.